To further explore the role of downstream molecules regulated by CTLA4 in the survival of CLL, we focused the subsequent studies on the expression of Bcl-2, an anti-apoptotic molecule. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.